One of the world's largest derivatives marketplaces reorganized into a clean product hierarchy and still landed in a feature factory. Yuval helped the transformation team stop pushing the team-level flywheel, move upstream to the portfolio, and run the operating-model shift itself as a product co-created with leaders.
Spectrum Healthcare needed IT, clinical, and operational leaders to move critical cross-cutting initiatives faster. Yuval helped launch a cross-functional SAFe-based operating cadence that improved collaboration, sped delivery on telemedicine and clinic initiatives, and strengthened business outcomes.
NEC was dealing with project chaos, weak product focus, and low predictability in a high-stakes engineering environment. Yuval helped combine Scrum, Kanban, and leadership-level transparency to create steadier flow and a stronger foundation for scale.
Molecule-to-Medicine Bio needed diverse R&D teams and portfolio companies to collaborate better under scientific uncertainty. Yuval introduced pragmatic Scrum and Kanban patterns, shared visibility, and iterative learning loops that improved traction, risk management, and cross-company alignment.
Dyno Therapeutics needed its biology, ML, and data teams to work as one innovation system rather than as siloed functions. Yuval helped redesign around shared outcomes and empirical feedback loops, reducing coordination drag and accelerating learning.
Gillette faced intense launch pressure on a next-generation razor across R&D, commercial, and manufacturing teams. Yuval introduced a pragmatic scaled-Scrum approach that surfaced risks early and helped the team launch faster with stronger market response.